"Proactive Medicine" By Dr. Jay Wohlgemuth

[Mercedes Millberry]

Jay Wohlgemuth, MD, VP Research & Development at VIA Pharmaceuticals applies molecular, genomic and imaging technologies to medical research and clinical programs. He was co-founder and Chief Medical Officer of XDx, Inc., a molecular diagnostics company. Holland Hall class of 1988, Harvard and Stanford educated, he is also the founder of Molecular Image, which is developing new methods to image cancer and neurologic diseases. His topic is "Proactive Medicine: Practical Applications of the Human Genome to Improve Patient Care."

The event is free and open to the public, though reservations are required. Please reserve your seat for this event by February 2, through Fay Palma at 918-481-1111 ext. 717 or fpalma@hollandhall.org. Visit www.hollandhall.org for more information.